Market Cap 206.31M
Revenue (ttm) 74.89M
Net Income (ttm) -43.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -58.37%
Debt to Equity Ratio 1.76
Volume 1,082,500
Avg Vol 1,315,748
Day's Range N/A - N/A
Shares Out 66.13M
Stochastic %K 82%
Beta 1.17
Analysts Strong Sell
Price Target $6.50

Company Profile

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific area...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 640 4202
Fax: 610 640 4206
Address:
3222 Phoenixville Pike, Malvern, United States
glistens
glistens Oct. 22 at 5:37 AM
$STIM Entering here. Very optimistically. If Sullivan can pull off the integration of Greenbrook and synergize manufacturing into clinic operations, the sky is the limit. Being that Neurostar is the not only empirically best TMS system, it's the only one approved for adolescents by the FDA, creating a giant moat in itself. Spravato being embraced by FDA adds a ton of potential to their valuation, which I don't believe is priced in as Greenbrook expands. The numbers are so juicy even with a rocky road we're still undervalued. There's serious potential here.
1 · Reply
SorosSonosSatoshi
SorosSonosSatoshi Oct. 3 at 5:02 PM
$STIM 2.666 the multimillion exodus tinnitus to locus
0 · Reply
DARKP00L
DARKP00L Oct. 3 at 2:51 PM
$STIM this stock is attracting a lot of interest. Be prepared for possible changes!
1 · Reply
SorosSonosSatoshi
SorosSonosSatoshi Oct. 2 at 6:56 PM
$STIM 2.34567890 all 3 eyes Expect the sharp stop loss marks to 1.666&1.88 range.. Tax sling season ahead
1 · Reply
theoptionsplug
theoptionsplug Sep. 17 at 10:46 PM
$STIM looking to bear flag, currently in the small pullback where you can add a put position Also the 200DMA is about to death cross with the 50 The reaction to the $2.80 level of support will set everything up
0 · Reply
GMExAPE
GMExAPE Sep. 17 at 9:35 PM
RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here. Historic short squeeze coming - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $API $CAAS $SLND $ZENA $STIM watchh
0 · Reply
prismmarketview
prismmarketview Sep. 17 at 3:32 PM
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 17 at 12:52 PM
$STIM New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) By Neuronetics | September 17, 2025, 8:32 AM
0 · Reply
YearOfTheRabbit
YearOfTheRabbit Sep. 17 at 12:41 PM
$STIM strange no buyers on good or
0 · Reply
Aismai
Aismai Sep. 15 at 8:15 PM
$STIM Its been a painful hold the last several months with the sp trending down but I'm still bullish as Google search interest is still on the rise. LFG!!
0 · Reply
Latest News on STIM
Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 12:53 PM EDT - 2 months ago

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript


Neuronetics Appoints New Chief Financial Officer

Jul 15, 2025, 7:30 AM EDT - 3 months ago

Neuronetics Appoints New Chief Financial Officer


Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

May 6, 2025, 9:57 AM EDT - 6 months ago

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript


Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs

Mar 29, 2025, 11:45 PM EDT - 7 months ago

Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs


Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 9:52 AM EST - 8 months ago

Neuronetics, Inc. (STIM) Q4 2024 Earnings Call Transcript


Neuronetics and Greenbrook TMS Announce Closing of Transaction

Dec 10, 2024, 10:00 AM EST - 11 months ago

Neuronetics and Greenbrook TMS Announce Closing of Transaction


Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:41 PM EST - 1 year ago

Neuronetics, Inc. (STIM) Q3 2024 Earnings Call Transcript


Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 1:59 PM EDT - 1 year ago

Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript


NeuroStar® Launches Better Me Provider Program Nationwide

Jul 1, 2024, 8:02 AM EDT - 1 year ago

NeuroStar® Launches Better Me Provider Program Nationwide


Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript

May 7, 2024, 5:16 PM EDT - 1 year ago

Neuronetics, Inc. (STIM) Q1 2024 Earnings Call Transcript


glistens
glistens Oct. 22 at 5:37 AM
$STIM Entering here. Very optimistically. If Sullivan can pull off the integration of Greenbrook and synergize manufacturing into clinic operations, the sky is the limit. Being that Neurostar is the not only empirically best TMS system, it's the only one approved for adolescents by the FDA, creating a giant moat in itself. Spravato being embraced by FDA adds a ton of potential to their valuation, which I don't believe is priced in as Greenbrook expands. The numbers are so juicy even with a rocky road we're still undervalued. There's serious potential here.
1 · Reply
SorosSonosSatoshi
SorosSonosSatoshi Oct. 3 at 5:02 PM
$STIM 2.666 the multimillion exodus tinnitus to locus
0 · Reply
DARKP00L
DARKP00L Oct. 3 at 2:51 PM
$STIM this stock is attracting a lot of interest. Be prepared for possible changes!
1 · Reply
SorosSonosSatoshi
SorosSonosSatoshi Oct. 2 at 6:56 PM
$STIM 2.34567890 all 3 eyes Expect the sharp stop loss marks to 1.666&1.88 range.. Tax sling season ahead
1 · Reply
theoptionsplug
theoptionsplug Sep. 17 at 10:46 PM
$STIM looking to bear flag, currently in the small pullback where you can add a put position Also the 200DMA is about to death cross with the 50 The reaction to the $2.80 level of support will set everything up
0 · Reply
GMExAPE
GMExAPE Sep. 17 at 9:35 PM
RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here. Historic short squeeze coming - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $API $CAAS $SLND $ZENA $STIM watchh
0 · Reply
prismmarketview
prismmarketview Sep. 17 at 3:32 PM
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 17 at 12:52 PM
$STIM New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar Advanced Therapy, to Treat Major Depressive Disorder (MDD) By Neuronetics | September 17, 2025, 8:32 AM
0 · Reply
YearOfTheRabbit
YearOfTheRabbit Sep. 17 at 12:41 PM
$STIM strange no buyers on good or
0 · Reply
Aismai
Aismai Sep. 15 at 8:15 PM
$STIM Its been a painful hold the last several months with the sp trending down but I'm still bullish as Google search interest is still on the rise. LFG!!
0 · Reply
Traderjoe2869
Traderjoe2869 Sep. 15 at 4:29 PM
$STIM weird drop
1 · Reply
Arcides
Arcides Sep. 15 at 4:28 PM
$STIM horrible price action last 4 days..losing 200dma
0 · Reply
KUWALSKY
KUWALSKY Sep. 8 at 6:53 PM
$SOUN and $STIM are the plays for the week
1 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 6:32 PM
$STIM Outstanding article that hits the mark on STIM's current state. So if you want to refresh your STIM insights or learn about STIM from scratch, this is a must read. https://beyondspx.com/quote/STIM/analysis/neuronetics-forging-a-vertically-integrated-future-in-mental-health-stim
0 · Reply
prismmarketview
prismmarketview Aug. 29 at 3:40 PM
$STIM sitting near its 200WMA
0 · Reply
Fugazi_
Fugazi_ Aug. 28 at 6:05 PM
$STIM News?
0 · Reply
mhaven2020
mhaven2020 Aug. 12 at 3:59 PM
$STIM closedsome here and $PAPL. Hopped in $BTBT and $ELDN for a few days. Want the alerts? Sign up through paypal in the catalog on our site. $2.99 per month gets 4 solid tickers a day that are a few days away from their move. Stop being late to the party!
0 · Reply
mhaven2020
mhaven2020 Aug. 11 at 11:06 AM
$STIM hello beautiful! $PAPL
0 · Reply
BioGem
BioGem Aug. 9 at 3:16 PM
$STIM Took a short on the strange pump after earning in the mid $4. Many critical issues: -While they kept the same revenue guidance, they applied a huge down guidance to their gross margins and increased significantly their future operating expenses = a lot more operating losses to be expected in 2025. -They pushed their ability to be cash flow positive further out. -Cash is too low at 11M in June = more debt and dilutions from the ATM are a certainty. -Heavy and expensive debt is already sitting on the balance sheet. -Current liabilities are increasing every quarter. -High short interest and analysts dropped their price targets.
0 · Reply
JarvisFlow
JarvisFlow Aug. 6 at 6:13 PM
Canaccord Genuity updates rating for Neuronetics ( $STIM ) to Buy, target set at 8 → 7.
0 · Reply
Shlobby
Shlobby Aug. 5 at 4:13 PM
Missed $UMAC this morning the. Caught dip at 10.30. Full position now. Cut a few $LC $STIM. Also added $GOGL
0 · Reply